BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35367355)

  • 1. Varicella zoster meningitis following COVID-19 vaccination: a report of two cases.
    Buranasakda M; Kotruchin P; Phanthachai K; Mootsikapun P; Chetchotisakd P
    Int J Infect Dis; 2022 Jun; 119():214-216. PubMed ID: 35367355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report.
    Medhat R; El Lababidi R; Abdelsalam M; Nusair A
    Int J Infect Dis; 2022 Jun; 119():184-186. PubMed ID: 35398296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Herpes Zoster Following Varicella Vaccination in Immunocompetent Young Children.
    Moodley A; Swanson J; Grose C; Bonthius DJ
    J Child Neurol; 2019 Mar; 34(4):184-188. PubMed ID: 30628536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
    Goldman GS; King PG
    Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serious neurological adverse events in immunocompetent children and adolescents caused by viral reactivation in the years following varicella vaccination.
    Ramachandran P; Grose C
    Rev Med Virol; 2024 May; 34(3):e2538. PubMed ID: 38658176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoster Meningitis in an Immunocompetent Child after COVID-19 Vaccination, California, USA.
    Daouk SK; Kamau E; Adachi K; Aldrovandi GM
    Emerg Infect Dis; 2022 Jul; 28(7):1523-1524. PubMed ID: 35680126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary varicella zoster infection compared to varicella vaccine reactivation associated meningitis in immunocompetent children.
    Amaral V; Shi JZ; Tsang AM; Chiu SS
    J Paediatr Child Health; 2021 Jan; 57(1):19-25. PubMed ID: 33295075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes Zoster Virus Reactivation in a 16 Year Old Female Post COVID-19 Vaccine. Case report and Review of the Literature.
    Alharbi S; Alsubaie M; Alzayyat R; Alattas B; AlAhmadi H; Alabdullatif H
    Med Arch; 2023 Apr; 77(2):146-149. PubMed ID: 37260797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus.
    Heusel EH; Grose C
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID 19 vaccination in an Asian Indian male.
    Mishra SB; Mahendradas P; Kawali A; Sanjay S; Shetty R
    Eur J Ophthalmol; 2023 Jan; 33(1):NP32-NP36. PubMed ID: 34541931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunization of adults against varicella and herpes zoster].
    Hanslik T; Blanchon T; Alvarez FP
    Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs.
    Gabutti G; Franchi M; Maniscalco L; Stefanati A
    Minerva Pediatr; 2016 Jun; 68(3):213-25. PubMed ID: 27125440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan.
    Uda K; Okubo Y; Tsuge M; Tsukahara H; Miyairi I
    Vaccine; 2023 Jul; 41(34):4958-4966. PubMed ID: 37400282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of reactivation of varicella-zoster virus after BNT162b2 vaccine second dose?
    Santovito LS; Pinna G
    Inflamm Res; 2021 Sep; 70(9):935-937. PubMed ID: 34390376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus.
    Hertel M; Heiland M; Nahles S; von Laffert M; Mura C; Bourne PE; Preissner R; Preissner S
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1342-1348. PubMed ID: 35470920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema nodosum after COVID-19 vaccine associated with varicella-zoster virus reactivation.
    Kobayashi E; Ohyama M; Yamazaki Y; Mizukawa Y
    Int J Dermatol; 2024 Feb; 63(2):e44-e46. PubMed ID: 38093470
    [No Abstract]   [Full Text] [Related]  

  • 19. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
    Levin MJ; DeBiasi RL; Bostik V; Schmid DS
    J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
    Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.